NEW YORK (GenomeWeb) –One BioMed and A*Star’s Genome Institute of Singapore (GIS) said on Monday that they have established a joint laboratory to develop molecular diagnostic assays for the Asian clinical infectious disease testing market.

The joint laboratory will focus on the development and integration of initial assays for One BioMed's platform.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.